Diabetes Prevention and Control in the Workplace: A Pilot Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00739336 |
|
Recruitment Status :
Completed
First Posted : August 21, 2008
Results First Posted : October 5, 2016
Last Update Posted : October 5, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Type 2 Diabetes Mellitus | Behavioral: Diabetes Prevention and Control | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 45 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | Diabetes Prevention and Control in the Workplace: A Pilot Study |
| Study Start Date : | July 2008 |
| Actual Primary Completion Date : | December 2014 |
| Actual Study Completion Date : | December 2014 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: A, 1
Intervention: Immediate 3 month program
|
Behavioral: Diabetes Prevention and Control
The program will be delivered over 3 months in 12 one hour weekly mid-day sessions at the worksite. The curriculum has been adapted from the Diabetes Prevention Program, the National Diabetes Education Program and Conversation maps from Healthy Interactions Inc. Topics relate to healthy eating, physical activity, coping with disease and depression, and cardiovascular disease prevention. Additional topics may be included per feedback and need of the participants. After completion of the 3 month program, there will be monthly meetings. |
|
No Intervention: A, 2
Wait-List Control
|
- Body Weight [ Time Frame: 3 months ]Weight loss in kg
- Fasting Glucose Level [ Time Frame: Baseline ]Fasting glucose (mg/dL)
- Fasting Lipid Profile [ Time Frame: Baseline ]LDL-cholesterol (mg/dL)
- Hemoglobin A1c [ Time Frame: baseline ]hemoglobin A1c (%)
- Waist Circumference [ Time Frame: baseline, 3, 6, 12 months ]
- Questionnaires [ Time Frame: baseline, 3, 6, 12 months ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Adult employees of Onondaga County
Exclusion Criteria:
- Not an employee of Onondaga County
- Less than age 18
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00739336
| United States, New York | |
| SUNY Upstate Medical University | |
| Syracuse, New York, United States, 13210 | |
| Principal Investigator: | Ruth S Weinstock, MD, PhD | State University of New York - Upstate Medical University |
| Responsible Party: | Ruth Weinstock, Distinguished Service Professor, State University of New York - Upstate Medical University |
| ClinicalTrials.gov Identifier: | NCT00739336 |
| Other Study ID Numbers: |
IRB#5657 NYSDOH Contract# C021750 Onondaga Cty,NY Contract#39407 |
| First Posted: | August 21, 2008 Key Record Dates |
| Results First Posted: | October 5, 2016 |
| Last Update Posted: | October 5, 2016 |
| Last Verified: | August 2016 |
|
diabetes mellitus obesity prevention |
|
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |

